A novel RANKL‐targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species
Guoju Hong(Guangzhou University of Chinese Medicine), Qiushi Wei(Guangzhou University of Chinese Medicine)
Cited by 74
Related Papers
Chrysosplenetin promotes osteoblastogenesis of bone marrow stromal cells via Wnt/β-catenin pathway and enhances osteogenesis in estrogen deficiency-induced bone loss
|Stem Cell Research & Therapy|2019|48
Icaritin promotes the osteogenesis of bone marrow mesenchymal stem cells via the regulation of sclerostin expression
|International Journal of Molecular Medicine|2020|22
Plasma 8-OHdG act as a biomarker for steroid-induced osteonecrosis of the femoral head
|BMC Musculoskeletal Disorders|2023|6